Brainstorm Cell Therapeutics, Inc.. (BCLI) NASDAQ
$0.55 0.02 (3.81%)
Market Cap: $37.25M
As of 04/24/24 04:00 PM EDT. Market closed.
Brainstorm Cell Therapeutics, Inc.. (BCLI)
NASDAQ
$0.55
0.02 (3.81%)
Market Cap: $37.25M
As of 04/24/24 04:00 PM EDT. Market closed.
Add to Portfolio
brainstorm cell therapeutics inc. (nasdaq:bcli), is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative disorders such as als (lou gehrig's disease), multiple sclerosis (ms) and parkinson’s disease (pd). these diseases have limited treatment options and as such represent unmet medical needs. nurown™ is brainstorm’s ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Chaim Lebovits
Full Time Employees
24
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Chaim Lebovits
Full Time Employees
24
Address
1325 Avenue of the Americas Fl 28, New York, New York, 10019-6583.
PRICE CHART FOR BRAINSTORM CELL THERAPEUTICS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.54
Previous Close
$0.53
Days Range
$0.52 - $0.55
52 week range
$0.13 - $3.34
Volume
186,427
Avg. Volume (30 days)
1,061,375
Market Cap
$37.25M
Dividend Yield
-
P/E
-
Shares Outstanding
68,341,857
Open
$0.54
Previous Close
$0.53
Days Range
$0.52 - $0.55
52 week range
$0.13 - $3.34
Volume
186,427
Avg. Volume (30 days)
1,061,375
Market Cap
$37.25M
Dividend Yield
-
P/E
-
Shares Outstanding
68,341,857
FINANCIAL STATEMENTS FOR BRAINSTORM CELL THERAPEUTICS, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR BRAINSTORM CELL THERAPEUTICS, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Lebovits Chaim | President & CEO | Apr 17, 2024 | Option Exercise | $0.55 | 130,000 | 70,941 | 728,493 | Apr 19, 2024, 06:05 AM |
| Lebovits Chaim | President & CEO | Apr 18, 2024 | Option Exercise | $0.53 | 115,072 | 60,470 | 843,565 | Apr 19, 2024, 06:05 AM |
| Lindborg Stacy | Co-Chief Executive Officer | Sep 01, 2023 | Buy | $1.77 | 11,500 | 20,402 | 181,500 | Sep 05, 2023, 05:16 PM |
| Shah Preetam | EVP, CFO and Treasurer | Dec 30, 2020 | Option Exercise | $4.64 | 25,000 | 116,000 | 11,600 | Dec 31, 2020, 09:20 PM |
| Abbhi Sankesh | Director | Jul 15, 2020 | Buy | $12.99 | 46,779 | 607,659 | 2,164,530 | Jul 16, 2020, 05:15 PM |
| Setboun David | EVP and COO | Jul 16, 2020 | Buy | $12.95 | 5,000 | 64,740 | 55,000 | Jul 16, 2020, 05:10 PM |
| ACC International Holdings Ltd. | Member of 10% owner group | Jul 13, 2020 | Sale | $13.52 | 40,000 | 540,952 | 93,306 | Jul 16, 2020, 05:05 PM |
| ACC International Holdings Ltd. | Member of 10% owner group | Jul 10, 2020 | Sale | $13.35 | 2,000 | 26,700 | 133,306 | Jul 16, 2020, 05:05 PM |
| ACC International Holdings Ltd. | Member of 10% owner group | Jul 09, 2020 | Sale | $13.13 | 3,500 | 45,939 | 135,306 | Jul 16, 2020, 05:05 PM |
| ACC International Holdings Ltd. | Member of 10% owner group | Jul 16, 2020 | Sale | $13.47 | 7,823 | 105,351 | 67,053 | Jul 16, 2020, 05:05 PM |
| ACC International Holdings Ltd. | Member of 10% owner group | Jul 15, 2020 | Sale | $13.12 | 18,430 | 241,715 | 74,876 | Jul 16, 2020, 05:05 PM |
| Kern Ralph Dr. | COO and Chief Medical Officer | Dec 24, 2019 | Buy | $3.88 | 3,000 | 11,640 | 115,655 | Dec 27, 2019, 07:01 AM |
| Shah Preetam | EVP, CFO and Treasurer | Dec 24, 2019 | Buy | $3.96 | 11,600 | 45,929 | 36,600 | Dec 27, 2019, 07:01 AM |
| Araya Arturo | Chief Commercial Officer | Dec 24, 2019 | Buy | $3.90 | 3,000 | 11,700 | 8,608 | Dec 27, 2019, 07:00 AM |
| ARBEL IRIT | Director | Aug 28, 2019 | Option Exercise | $2.25 | 13,332 | 29,997 | 169,165 | Aug 30, 2019, 05:02 PM |
| ARBEL IRIT | Director | Aug 28, 2019 | Sale | $3.67 | 13,332 | 48,891 | 155,833 | Aug 30, 2019, 05:02 PM |
| Almenoff June Sherie | Director | Jan 04, 2019 | Buy | $3.39 | 1,475 | 5,000 | 7,175 | Jan 08, 2019, 09:00 AM |
| Almenoff June Sherie | Director | Mar 15, 2018 | Buy | $3.50 | 5,700 | 19,950 | 5,700 | Mar 20, 2018, 10:50 AM |
| Kern Ralph Dr. | COO and Chief Medical Officer | Mar 15, 2018 | Buy | $3.60 | 5,000 | 17,997 | 40,885 | Mar 20, 2018, 10:48 AM |
| Kern Ralph Dr. | COO and Chief Medical Officer | Mar 15, 2018 | Option Exercise | $3.60 | 5,000 | 17,997 | 40,885 | Mar 19, 2018, 04:05 PM |
| Almenoff June Sherie | Director | Mar 15, 2018 | Option Exercise | $3.50 | 5,700 | 19,950 | 5,700 | Mar 16, 2018, 06:06 AM |
| ARBEL IRIT | Director | Aug 31, 2017 | Buy | $4.26 | 2,500 | 10,650 | 155,833 | Aug 31, 2017, 04:08 PM |
| Yablonka Uri | EVP & Chief Business Officer | Aug 23, 2017 | Buy | $3.98 | 2,000 | 7,960 | 7,543 | Aug 23, 2017, 02:22 PM |
| SHORR ROBERT G L | Director | Dec 16, 2015 | Sale | $2.71 | 10,800 | 29,268 | 28,399 | Dec 17, 2015, 05:04 PM |
| Friedman Mordechai | Director | Dec 14, 2015 | Option Exercise | $0.75 | 5,000 | 3,750 | 5,000 | Dec 16, 2015, 05:06 PM |
| Friedman Mordechai | Director | Dec 14, 2015 | Sale | $2.57 | 5,000 | 12,850 | 0 | Dec 16, 2015, 05:06 PM |
| TAUB MALCOLM S | Director | Dec 15, 2015 | Sale | $2.59 | 11,263 | 29,171 | 8,666 | Dec 16, 2015, 05:05 PM |
| TAUB MALCOLM S | Director | Dec 14, 2015 | Sale | $2.61 | 30,479 | 79,550 | 19,929 | Dec 16, 2015, 05:05 PM |
| SHORR ROBERT G L | Director | Dec 10, 2015 | Sale | $2.71 | 5,500 | 14,905 | 44,499 | Dec 14, 2015, 05:06 PM |
| SHORR ROBERT G L | Director | Dec 11, 2015 | Sale | $2.56 | 5,300 | 13,568 | 39,199 | Dec 14, 2015, 05:06 PM |
| TAUB MALCOLM S | Director | Dec 11, 2015 | Sale | $2.66 | 980 | 2,607 | 50,408 | Dec 14, 2015, 05:05 PM |
| TAUB MALCOLM S | Director | Dec 10, 2015 | Sale | $2.74 | 12,500 | 34,250 | 51,388 | Dec 14, 2015, 05:05 PM |
| ACC International Holdings Ltd. | Member of 10% owner group | Oct 01, 2015 | Buy | $2.58 | 2,000 | 5,160 | 138,806 | Oct 02, 2015, 04:00 PM |
| ACC International Holdings Ltd. | Member of 10% owner group | Sep 30, 2015 | Buy | $2.34 | 9,200 | 21,528 | 136,806 | Oct 01, 2015, 11:17 AM |
| Bibring Yoram | Chief Financial Officer | Aug 20, 2015 | Buy | $3.04 | 8,500 | 25,840 | 50,000 | Aug 21, 2015, 09:00 AM |
| Bibring Yoram | Chief Financial Officer | Aug 17, 2015 | Buy | $2.92 | 41,500 | 121,180 | 41,500 | Aug 19, 2015, 09:00 AM |
| Fiorino Anthony S. | Chief Executive Officer | Oct 15, 2014 | Buy | $3.60 | 500 | 1,798 | 2,500 | Oct 15, 2014, 05:22 PM |
| ACC International Holdings Ltd. | Member of 10% owner group | Oct 10, 2014 | Buy | $4.06 | 8,600 | 34,895 | 127,606 | Oct 15, 2014, 09:03 AM |
| ACC International Holdings Ltd. | Oct 01, 2014 | Buy | $4.08 | 3,600 | 14,688 | 119,006 | Oct 01, 2014, 03:26 PM | |
| ACC International Holdings Ltd. | Sep 30, 2014 | Buy | $4.29 | 1,500 | 6,428 | 115,406 | Oct 01, 2014, 03:26 PM | |
| ACC International Holdings Ltd. | Sep 29, 2014 | Buy | $4.14 | 1,600 | 6,623 | 113,906 | Oct 01, 2014, 03:26 PM | |
| ACC International Holdings Ltd. | Member of 10% owner group | Sep 22, 2014 | Buy | $4.24 | 8,500 | 36,057 | 112,306 | Sep 24, 2014, 11:03 AM |
| ACC International Holdings Ltd. | Member of 10% owner group | Sep 19, 2014 | Buy | $3.92 | 2,500 | 9,790 | 103,806 | Sep 24, 2014, 11:03 AM |
| Fiorino Anthony S. | Chief Executive Officer | Sep 18, 2014 | Buy | $3.84 | 800 | 3,072 | 2,000 | Sep 19, 2014, 05:56 PM |
| Fiorino Anthony S. | Chief Executive Officer | Sep 15, 2014 | Buy | $0.29 | 8,000 | 2,288 | 18,000 | Sep 16, 2014, 10:05 AM |
| Fiorino Anthony S. | Chief Executive Officer | Sep 12, 2014 | Buy | $0.28 | 10,000 | 2,837 | 10,000 | Sep 16, 2014, 10:05 AM |
| ACC International Holdings Ltd. | Jun 16, 2014 | Buy | $0.29 | 130,000 | 37,700 | 1,519,600 | Jun 20, 2014, 11:16 AM | |
| ACC International Holdings Ltd. | Member of 10% owner group | Jun 13, 2014 | Buy | $0.35 | 150,000 | 52,500 | 1,389,600 | Jun 16, 2014, 04:05 PM |
| ACC International Holdings Ltd. | Member of 10% owner group | Apr 28, 2014 | Buy | $0.30 | 939,600 | 281,880 | 1,239,600 | May 02, 2014, 11:12 AM |
| SHORR ROBERT G L | Director | Dec 05, 2011 | Sale | $0.26 | 98,333 | 25,144 | 230,000 | Dec 07, 2011, 05:36 PM |
| SHORR ROBERT G L | Director | Nov 28, 2011 | Sale | $0.27 | 10,000 | 2,700 | 328,333 | Nov 30, 2011, 07:34 PM |
| SHORR ROBERT G L | Director | Oct 05, 2011 | Sale | $0.30 | 95,000 | 28,852 | 338,333 | Oct 06, 2011, 08:34 PM |
| SHORR ROBERT G L | Director | Oct 04, 2011 | Sale | $0.31 | 105,000 | 32,855 | 433,333 | Oct 06, 2011, 08:34 PM |
| TAUB MALCOLM S | Director | Jul 08, 2011 | Sale | $0.46 | 100,000 | 45,540 | 238,333 | Jul 25, 2011, 03:01 PM |
| ACC International Holdings Ltd. | Member of 10% owner group | Jun 16, 2011 | Buy | $0.28 | 100,000 | 28,000 | 300,000 | Jun 20, 2011, 02:00 PM |
| ACC International Holdings Ltd. | Member of 10% owner group | May 18, 2011 | Buy | $0.30 | 100,000 | 30,000 | 100,000 | Jun 15, 2011, 10:19 AM |
| ACC International Holdings Ltd. | Member of 10% owner group | May 23, 2011 | Buy | $0.27 | 100,000 | 27,380 | 100,000 | Jun 15, 2011, 10:19 AM |
| TAUB MALCOLM S | Director | Jun 06, 2011 | Sale | $0.28 | 33,023 | 9,246 | 0 | Jun 08, 2011, 07:36 PM |
| TAUB MALCOLM S | Director | May 18, 2011 | Sale | $0.30 | 10,250 | 3,075 | 33,032 | May 19, 2011, 05:13 PM |
| TAUB MALCOLM S | Director | May 17, 2011 | Sale | $0.30 | 61,400 | 18,432 | 43,282 | May 19, 2011, 05:13 PM |
| ACCBT Corp. | 10% Owner | Jan 23, 2011 | Option Exercise | $0.12 | 10,499,999 | 1,260,000 | 29,006,924 | Apr 28, 2011, 06:15 PM |
| ACCBT Corp. | 10% Owner | Sep 08, 2008 | Option Exercise | $0.18 | 4,125,000 | 749,925 | 18,506,925 | Apr 28, 2011, 06:15 PM |
| TAUB MALCOLM S | Director | Apr 12, 2011 | Sale | $0.30 | 3,000 | 900 | 269,682 | Apr 14, 2011, 04:09 PM |
| TAUB MALCOLM S | Director | Apr 13, 2011 | Sale | $0.30 | 165,000 | 49,500 | 104,682 | Apr 14, 2011, 04:09 PM |
| TAUB MALCOLM S | Director | Apr 07, 2011 | Sale | $0.30 | 5,000 | 1,500 | 272,682 | Apr 11, 2011, 06:23 PM |
| TAUB MALCOLM S | Director | Apr 05, 2011 | Sale | $0.30 | 97,966 | 29,498 | 277,682 | Apr 06, 2011, 04:10 PM |
| TAUB MALCOLM S | Director | Apr 04, 2011 | Sale | $0.30 | 6,500 | 1,950 | 375,648 | Apr 06, 2011, 04:10 PM |
| TAUB MALCOLM S | Director | Apr 01, 2011 | Sale | $0.30 | 7,354 | 2,206 | 382,148 | Apr 04, 2011, 06:37 PM |
| TAUB MALCOLM S | Director | Mar 31, 2011 | Sale | $0.30 | 20,000 | 6,000 | 389,502 | Apr 04, 2011, 06:37 PM |
| TAUB MALCOLM S | Director | Mar 22, 2011 | Sale | $0.30 | 43,630 | 13,089 | 409,502 | Mar 24, 2011, 04:08 PM |
| TAUB MALCOLM S | Director | Mar 14, 2011 | Sale | $0.31 | 40,400 | 12,322 | 453,132 | Mar 16, 2011, 04:03 PM |
| TAUB MALCOLM S | Director | Mar 10, 2011 | Sale | $0.31 | 50,000 | 15,500 | 493,532 | Mar 14, 2011, 04:06 PM |
| TAUB MALCOLM S | Director | Mar 09, 2011 | Sale | $0.31 | 50,000 | 15,500 | 543,532 | Mar 10, 2011, 06:22 PM |
| TAUB MALCOLM S | Director | Mar 08, 2011 | Sale | $0.32 | 81,468 | 26,330 | 593,532 | Mar 10, 2011, 06:22 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Lebovits Chaim | President & CEO | 04/17/2024 | 70,941 |
| Lebovits Chaim | President & CEO | 04/18/2024 | 60,470 |
| Lindborg Stacy | Co-Chief Executive Officer | 09/01/2023 | 20,402 |
| Shah Preetam | EVP, CFO and Treasurer | 12/30/2020 | 116,000 |
| Abbhi Sankesh | Director | 07/15/2020 | 607,659 |
| Setboun David | EVP and COO | 07/16/2020 | 64,740 |
| ACC International Holdings Ltd. | Member of 10% owner group | 07/13/2020 | 540,952 |
| ACC International Holdings Ltd. | Member of 10% owner group | 07/10/2020 | 26,700 |
| ACC International Holdings Ltd. | Member of 10% owner group | 07/09/2020 | 45,939 |
| ACC International Holdings Ltd. | Member of 10% owner group | 07/16/2020 | 105,351 |
| ACC International Holdings Ltd. | Member of 10% owner group | 07/15/2020 | 241,715 |
| Kern Ralph Dr. | COO and Chief Medical Officer | 12/24/2019 | 11,640 |
| Shah Preetam | EVP, CFO and Treasurer | 12/24/2019 | 45,929 |
| Araya Arturo | Chief Commercial Officer | 12/24/2019 | 11,700 |
| ARBEL IRIT | Director | 08/28/2019 | 29,997 |
| ARBEL IRIT | Director | 08/28/2019 | 48,891 |
| Almenoff June Sherie | Director | 01/04/2019 | 5,000 |
| Almenoff June Sherie | Director | 03/15/2018 | 19,950 |
| Kern Ralph Dr. | COO and Chief Medical Officer | 03/15/2018 | 17,997 |
| Kern Ralph Dr. | COO and Chief Medical Officer | 03/15/2018 | 17,997 |
| Almenoff June Sherie | Director | 03/15/2018 | 19,950 |
| ARBEL IRIT | Director | 08/31/2017 | 10,650 |
| Yablonka Uri | EVP & Chief Business Officer | 08/23/2017 | 7,960 |
| SHORR ROBERT G L | Director | 12/16/2015 | 29,268 |
| Friedman Mordechai | Director | 12/14/2015 | 3,750 |
| Friedman Mordechai | Director | 12/14/2015 | 12,850 |
| TAUB MALCOLM S | Director | 12/15/2015 | 29,171 |
| TAUB MALCOLM S | Director | 12/14/2015 | 79,550 |
| SHORR ROBERT G L | Director | 12/10/2015 | 14,905 |
| SHORR ROBERT G L | Director | 12/11/2015 | 13,568 |
| TAUB MALCOLM S | Director | 12/11/2015 | 2,607 |
| TAUB MALCOLM S | Director | 12/10/2015 | 34,250 |
| ACC International Holdings Ltd. | Member of 10% owner group | 10/01/2015 | 5,160 |
| ACC International Holdings Ltd. | Member of 10% owner group | 09/30/2015 | 21,528 |
| Bibring Yoram | Chief Financial Officer | 08/20/2015 | 25,840 |
| Bibring Yoram | Chief Financial Officer | 08/17/2015 | 121,180 |
| Fiorino Anthony S. | Chief Executive Officer | 10/15/2014 | 1,798 |
| ACC International Holdings Ltd. | Member of 10% owner group | 10/10/2014 | 34,895 |
| ACC International Holdings Ltd. | 10/01/2014 | 14,688 | |
| ACC International Holdings Ltd. | 09/30/2014 | 6,428 | |
| ACC International Holdings Ltd. | 09/29/2014 | 6,623 | |
| ACC International Holdings Ltd. | Member of 10% owner group | 09/22/2014 | 36,057 |
| ACC International Holdings Ltd. | Member of 10% owner group | 09/19/2014 | 9,790 |
| Fiorino Anthony S. | Chief Executive Officer | 09/18/2014 | 3,072 |
| Fiorino Anthony S. | Chief Executive Officer | 09/15/2014 | 2,288 |
| Fiorino Anthony S. | Chief Executive Officer | 09/12/2014 | 2,837 |
| ACC International Holdings Ltd. | 06/16/2014 | 37,700 | |
| ACC International Holdings Ltd. | Member of 10% owner group | 06/13/2014 | 52,500 |
| ACC International Holdings Ltd. | Member of 10% owner group | 04/28/2014 | 281,880 |
| SHORR ROBERT G L | Director | 12/05/2011 | 25,144 |
| SHORR ROBERT G L | Director | 11/28/2011 | 2,700 |
| SHORR ROBERT G L | Director | 10/05/2011 | 28,852 |
| SHORR ROBERT G L | Director | 10/04/2011 | 32,855 |
| TAUB MALCOLM S | Director | 07/08/2011 | 45,540 |
| ACC International Holdings Ltd. | Member of 10% owner group | 06/16/2011 | 28,000 |
| ACC International Holdings Ltd. | Member of 10% owner group | 05/18/2011 | 30,000 |
| ACC International Holdings Ltd. | Member of 10% owner group | 05/23/2011 | 27,380 |
| TAUB MALCOLM S | Director | 06/06/2011 | 9,246 |
| TAUB MALCOLM S | Director | 05/18/2011 | 3,075 |
| TAUB MALCOLM S | Director | 05/17/2011 | 18,432 |
| ACCBT Corp. | 10% Owner | 01/23/2011 | 1,260,000 |
| ACCBT Corp. | 10% Owner | 09/08/2008 | 749,925 |
| TAUB MALCOLM S | Director | 04/12/2011 | 900 |
| TAUB MALCOLM S | Director | 04/13/2011 | 49,500 |
| TAUB MALCOLM S | Director | 04/07/2011 | 1,500 |
| TAUB MALCOLM S | Director | 04/05/2011 | 29,498 |
| TAUB MALCOLM S | Director | 04/04/2011 | 1,950 |
| TAUB MALCOLM S | Director | 04/01/2011 | 2,206 |
| TAUB MALCOLM S | Director | 03/31/2011 | 6,000 |
| TAUB MALCOLM S | Director | 03/22/2011 | 13,089 |
| TAUB MALCOLM S | Director | 03/14/2011 | 12,322 |
| TAUB MALCOLM S | Director | 03/10/2011 | 15,500 |
| TAUB MALCOLM S | Director | 03/09/2011 | 15,500 |
| TAUB MALCOLM S | Director | 03/08/2011 | 26,330 |
Load More Insider Transactions
FUNDS WITH A POSITION IN BRAINSTORM CELL THERAPEUTICS, INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 466,355 | 0% | -0.23% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 357,041 | 0.00001% | 14.89% | Other |
CHANGE IN SHARES OUTSTANDING FOR BRAINSTORM CELL THERAPEUTICS, INC.
STOCK BUYBACKS FOR BRAINSTORM CELL THERAPEUTICS, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
16.46%
1Q
06/30/2023
29.83%
2Q
12/31/2022
40.74%
4Q
09/30/2022
41.22%
5Q
06/30/2022
41.25%
6Q
03/31/2022
41.44%
7Q
12/31/2021
41.95%
8Q
09/30/2021
41.96%
9Q
06/30/2021
41.90%
10Q
03/31/2021
43.99%
11Q
12/31/2020
54.74%
12Q
09/30/2020
65.43%
13Q
06/30/2020
76.05%
14Q
03/31/2020
81.32%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BRAINSTORM CELL THERAPEUTICS, INC.
LOADING...